CISPVINO
Cancer Type: Lung, Non-Small Cell Intent: Palliative
Regimen Category: Evidence-Informed
Regimen Category: Evidence-Informed
Regimen Monograph
Jan 2018
Patient Info Sheet
May 2016
CISplatin-Vinorelbine is a drug combination for treating non-small cell lung cancer.